As Amgen sinks executives dump stock

images-1
Well the rich get richer and the common shareholders get screwed. According to an article in this morning's Ventura County Star, several executive at Amgen sold company stock as the study on two of it's drug was completed and months before investors received the information. This sends out a great message to the public and Amgen employees who are waiting to hear if any layoffs are going to effect their livelihood. Read More...
|

Tough times agead for Amgen

images
I am sure there will be some executives at Amgen who will be reading the Long Tail after possibly losing possibly $2 billion in sales from it's top selling product Aranesp. What surprises me is that most pharmaceutical companies continue to rely on blockbusters to drive their profits at a time when it is getting harder and harder to develop and launch blockbuster products. Read More...
|